FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Lawsuit Against FDA and Livestock/Poultry Antibiotic Use

Several public health advocacy groups sue FDA, challenging its 2021 denial of a citizen petition that sought the withdrawal of medically important ant...

Medical Devices

FDA Funding Opportunity for Pediatric Device Consortia

FDA posts a new funding opportunity for its Pediatric Device Consortia grants program, which is open for applications through 3/29.

latest-news-card-1
Human Drugs

New Data Support Carvykti sNDA in Multiple Myeloma

Janssen Pharmaceutical says it will submit an NDA supplement for Carvykti (ciltacabtagene autoleucel; cilta-cel) after announcing favorable data from ...

latest-news-card-1
Human Drugs

Vanda Petitions FDA Over Teva Non-BrailleLabeling

Vanda Pharmaceuticals petitions FDA to revoke the approval of a Teva ANDA for a generic copy of Vandas Hetlioz (tasimelteon) because Tevas product fai...

latest-news-card-1
Human Drugs

FDA Denies Petition on Jakafi Safety Labeling

FDA denies a 3/2021 petition filed by Loeb & Loeb that asked the agency to take specific actions concerning the adequacy of safety labeling for Incyte...

latest-news-card-1
FDA General

Eschoo Reelected as Ranking Dem on Health Subcommittee

Democrat members of the House Energy and Commerce Committee vote Rep. Anna G. Eshoo (D-CA) as ranking Democrat on the Health Subcommittee.

latest-news-card-1
Medical Devices

LivaNova Again Recalls LifeSPARC Controller Over Software

LivaNova (TandemLife) recalls its LifeSPARC Controller due to a problematic software update that was designed to address a previous software malfuncti...

latest-news-card-1
Federal Register

FDA History Office Now Under Office of Operations

Federal Register notice: FDAs Office of Operations (OO), Office of Enterprise Management Services (OEMS) modifies its organizational structure to add ...

latest-news-card-1
Human Drugs

Lilly Gets Accelerated Approval for Lymophoma Drug

FDA grants Eli Lilly accelerated approval for Jaypirca (pirtobrutinib) for treating certain relapsed or refractory mantle cell lymphoma patients.

latest-news-card-1
Human Drugs

Rep. Guthrie to Chair FDA Oversight Committee

House leaders tap Representative Brett Guthrie (R-KY) to serve as chair of the House Energy and Commerce Committees Health Subcommittee, which oversee...